Concepedia

Tímea Balatoni

TB

9

Publications

258

Citations

9

H-Index

2014

Active since

Affiliations

National Institute of Oncology(Current)

Semmelweis University

Harvard University

Massachusetts General Hospital

University of Szeged

Tímea Balatoni is an author at National Institute of Oncology specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2014–2022

9

Publications

9

Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy

Tímea Balatoni, Anita Mohos, Eszter Papp et al. · Cancer Immunology Immunotherapy · 2017 · 76 citations · Full text

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Vera Hirsh, Sandro Pignata, Melissa Bersanelli et al. · Journal of Translational Medicine · 2017 · 43 citations · Full text

Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Tímea Balatoni, Andrea Ladányi, Georgina Fröhlich et al. · Pathology & Oncology Research · 2018 · 30 citations

, , +10

Melanoma and immunotherapy bridge 2015

Vashisht Gopal Yennu Nanda, Weiyi Peng, Patrick Hwu et al. · Journal of Translational Medicine · 2016 · 24 citations · Full text

Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival Data

Kata Czirbesz, Eszter Gorka, Tímea Balatoni et al. · Pathology & Oncology Research · 2017 · 24 citations

, , +7

Rows per page

1–5 of 9